Sign in

CIK 0001907108 · <br>Emerging growth company

Lexeo Therapeutics, Inc.

Sign in to watch
Ticker
LXEO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
854012572
Phone
(212) 547-9879
Business address
345 PARK AVENUE SOUTH, FLOOR 6, NEW YORK, NY, 10010
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$43,228
in 3 filings

Net −$43,228. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Tamayo Louis Edward −$20K Chief Financial Officer sold 4% of stake
  2. Townsend Richard Nolan −$17K Chief Executive Officer sold <1% of stake
  3. Otero Jose Manuel −$6K Chief Operating Officer sold <1% of stake
Date Insider Transaction Shares Price Value Owned after
2026-09-24 Bhalla Narinder Pal Chief Medical Officer Grant or award · Stock Option (right to buy) +54,750 54,750
2026-09-24 Tamayo Louis Edward Chief Financial Officer Grant or award · Stock Option (right to buy) +54,750 54,750
2026-09-24 Otero Jose Manuel Chief Operating Officer Grant or award · Stock Option (right to buy) +54,750 54,750
2026-09-24 Townsend Richard Nolan Chief Executive Officer Grant or award · Stock Option (right to buy) +145,500 145,500
2026-09-14 Bhalla Narinder Pal Chief Medical Officer Grant or award +2,714 $3.58 $10K 84,908
2026-09-14 Otero Jose Manuel Chief Operating Officer Grant or award +2,110 $2.64 $6K 138,288
2026-09-14 Townsend Richard Nolan Chief Executive Officer Grant or award +2,306 $2.64 $6K 376,778
2026-08-18 Tamayo Louis Edward Chief Financial Officer Sale −4,117 $4.91 $20K 92,907
2026-08-18 Otero Jose Manuel Chief Operating Officer Sale −1,304 $4.96 $6K 136,178
2026-08-18 Townsend Richard Nolan Chief Executive Officer Sale −3,345 $4.95 $17K 374,472
2026-07-01 Bhalla Narinder Pal Chief Medical Officer Sale −22,306 $4.42 $99K 82,194
2026-07-01 Tamayo Louis Edward Chief Financial Officer Sale −4,641 $4.49 $21K 97,024
2026-07-01 Otero Jose Manuel Chief Operating Officer Sale −4,666 $4.48 $21K 137,482
2026-07-01 Townsend Richard Nolan Chief Executive Officer Sale −25,947 $4.48 $116K 377,817
2026-06-29 Bhalla Narinder Pal Chief Medical Officer Grant or award +55,000 104,500
2026-06-29 Tamayo Louis Edward Chief Financial Officer Grant or award +12,000 101,665
2026-06-29 Otero Jose Manuel Chief Operating Officer Grant or award +12,060 142,148
2026-06-29 Townsend Richard Nolan Chief Executive Officer Grant or award +67,000 403,764
2026-06-25 COOPERSTONE BRENDA Director Grant or award · Stock Option (right to buy) +35,000 35,000
2026-06-25 Tanguler Tolga Director Grant or award · Stock Option (right to buy) +35,000 35,000

Page 1 of 9 · 165 trades